Filing Details
- Accession Number:
- 0000937556-15-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-10 16:12:01
- Reporting Period:
- 2015-04-08
- Filing Date:
- 2015-04-10
- Accepted Time:
- 2015-04-10 16:12:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1198927 | Sanford Fitch | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-04-08 | 2,000 | $12.00 | 63,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-04-08 | 2,000 | $34.57 | 61,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (Right to Buy) | Acquisiton | 2015-04-08 | 2,000 | $0.00 | 2,000 | $12.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
61,000 | 2007-11-03 | 2016-11-01 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 19, 2014, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- This option was granted on November 3, 2006 and was exercisable as it vested. This option vested over a five-year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.